Emergent BioSolutions Reports Second Quarter 2026 Financial Results
Go back to Emergent BioSolutions Reports Second Quarter 2026 Financial Results| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.83 +0.07 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.76 | 52 Week High | $44.38 | |||
| Open | $6.73 | 52 Week Low | $24.47 | |||
| Day High | $6.86 | P/E | 341.50 | |||
| Day Low | $6.73 | EPS | $0.02 | |||
| Volume | 49,997 | |||||

